Update: 05.11.2019 13:19
Published: 05.11.2019, 13:19
Prague – Modern diabetes drugs that also solve heart disease are more expensive than standard treatment, therefore do not allow health insurance companies to prescribe each patient. At the same time, these products reduce the complications of diabetes, which costs the Czech health industry two-thirds of the cost of treating diabetes. Martin Haluzík, director of the Department of Experimental Diabetology at the Institute of Clinical and Experimental Medicine, said this at today's press conference.
. therefore, the goal was to reduce blood sugar, said Josef Kořínek of II.
According to him, modern drugs focus on reducing the complications of the heart and blood vessels and reducing the patient's weight. They are based on a body-specific hormone that promotes the production of insulin and at the same time reduces the production of the hormone glucagon, which in turn acts against insulin
However, due to health insurance regulations, some patients have to pay for all or part of their treatment, then be reimbursed after to have reached the limit of protection for drug supplements. "Early use of this treatment can prevent the development of long-term complications in many patients and thus save significant resources," Haluzík added.
Southern Moravian region and Prague. According to experts, it is important to detect the disease in time and should be directed by general practitioners during preventive examinations. On Thursday, November 14, I celebrate World Diabetes Day.